Heart, brain, kidney, liver are just the start
One of the most common side effects of GLP-1 medications is fatigue
A compounded version is prepared for an individual patient and is not FDA approved, so its safety depends on the pharmacys sourcing, process controls, and testing
Patients May Have the Best Results Staying on These Medications The trials specifically looked at weight loss results, but doctors say the findings suggest that staying on a maintenance dose of medication can support improvements in heart health and blood sugar management
1 , 2 GLP-1 analogs came to market in 2005, and since then, the Food and Drug Administration (FDA) has approved six GLP-1s, with semaglutide being the seventh approved in the United States and the second indicated for obesity treatment, regardless of diabetes diagnosis
At our practice, your care will always be guided by evidence-based medicine and personalized attention